FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2084876139> ?p ?o ?g. }

• W2084876139 endingPage "1008" @default.
• W2084876139 startingPage "1002" @default.
• W2084876139 abstract "This open-label, rater-blinded, parallel-group study was designed to evaluate noninferiority of paliperidone palmitate (PP), a once-monthly injectable atypical antipsychotic, to once-biweekly risperidone long-acting injectable (RIS-LAI) in adult Chinese patients with acute schizophrenia. Eligible Chinese adults (N=452) with schizophrenia were randomized (1:1) to either PP (N=229; deltoid injections on day 1 [150 mg eq.] and day 8 [100 mg eq.]; then once-monthly deltoid or gluteal injections, flexibly dosed [50, 100, or 150 mg eq.]), or RIS-LAI (N=223; once-biweekly gluteal injections, flexibly dosed [25, 37.5 or 50 mg]). RIS-LAI-treated patients received oral risperidone supplementation (1-6 mg/day) at initiation and with RIS-LAI dose increases. Mean (SD) Positive and Negative Syndrome Scale (PANSS) total score at baseline was 83.2 (12.44). Mean (SD) change from baseline to endpoint in PANSS total scores (primary efficacy measure) was: -23.6 (16.28) for PP group and -26.9 (15.43) for RIS-LAI group. PP was noninferior to RIS-LAI (least squares mean difference [95% CI]: -2.3 [-5.20; 0.63]; predetermined non-inferiority margin: -5.5). Mean (SD) change from baseline to endpoint in Clinical Global Impression-Severity scale score was: -1.5 (1.24; PP group), -1.7 (1.16; RIS-LAI group) and in Personal and Social Performance Scale scores was: 16.8 (14.76; PP group), 18.6 (13.92; RIS-LAI group). The incidence of treatment-emergent adverse events (TEAEs) was similar between the two groups (73% [PP]; 75% [RIS-LAI]). The most common TEAEs were akathisia, tremor, and insomnia. The study demonstrated the noninferiority of PP (50-150 mg eq., flexibly dosed, without oral paliperidone supplementation) to risperidone-LAI (25-50 mg, flexibly dosed, with oral risperidone supplementation) for the treatment of acute schizophrenia in adult Chinese patients. PP injections were generally tolerable, and no new safety signals were detected in this population." @default.
• W2084876139 created "2016-06-24" @default.
• W2084876139 creator A5005356869 @default.
• W2084876139 creator A5013171074 @default.
• W2084876139 creator A5022187718 @default.
• W2084876139 creator A5077638637 @default.
• W2084876139 creator A5084163137 @default.
• W2084876139 date "2011-06-01" @default.
• W2084876139 modified "2023-10-15" @default.
• W2084876139 title "A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia" @default.
• W2084876139 cites W1906145619 @default.
• W2084876139 cites W1924220013 @default.
• W2084876139 cites W1935737369 @default.
• W2084876139 cites W1981831195 @default.
• W2084876139 cites W1986060217 @default.
• W2084876139 cites W1999689270 @default.
• W2084876139 cites W2022592863 @default.
• W2084876139 cites W2027885026 @default.
• W2084876139 cites W2061331619 @default.
• W2084876139 cites W2064036552 @default.
• W2084876139 cites W2072686355 @default.
• W2084876139 cites W2077138902 @default.
• W2084876139 cites W2096271865 @default.
• W2084876139 cites W2107962758 @default.
• W2084876139 cites W2140606211 @default.
• W2084876139 cites W2142625643 @default.
• W2084876139 cites W2165379748 @default.
• W2084876139 cites W2174462147 @default.
• W2084876139 cites W4244847179 @default.
• W2084876139 doi "https://doi.org/10.1016/j.pnpbp.2011.02.001" @default.
• W2084876139 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21315787" @default.
• W2084876139 hasPublicationYear "2011" @default.
• W2084876139 type Work @default.
• W2084876139 sameAs 2084876139 @default.
• W2084876139 citedByCount "84" @default.
• W2084876139 countsByYear W20848761392012 @default.
• W2084876139 countsByYear W20848761392013 @default.
• W2084876139 countsByYear W20848761392014 @default.
• W2084876139 countsByYear W20848761392015 @default.
• W2084876139 countsByYear W20848761392016 @default.
• W2084876139 countsByYear W20848761392017 @default.
• W2084876139 countsByYear W20848761392018 @default.
• W2084876139 countsByYear W20848761392019 @default.
• W2084876139 countsByYear W20848761392020 @default.
• W2084876139 countsByYear W20848761392021 @default.
• W2084876139 countsByYear W20848761392022 @default.
• W2084876139 countsByYear W20848761392023 @default.
• W2084876139 crossrefType "journal-article" @default.
• W2084876139 hasAuthorship W2084876139A5005356869 @default.
• W2084876139 hasAuthorship W2084876139A5013171074 @default.
• W2084876139 hasAuthorship W2084876139A5022187718 @default.
• W2084876139 hasAuthorship W2084876139A5077638637 @default.
• W2084876139 hasAuthorship W2084876139A5084163137 @default.
• W2084876139 hasConcept C118552586 @default.
• W2084876139 hasConcept C126322002 @default.
• W2084876139 hasConcept C142724271 @default.
• W2084876139 hasConcept C168563851 @default.
• W2084876139 hasConcept C197934379 @default.
• W2084876139 hasConcept C203092338 @default.
• W2084876139 hasConcept C204787440 @default.
• W2084876139 hasConcept C27081682 @default.
• W2084876139 hasConcept C2776000289 @default.
• W2084876139 hasConcept C2776412080 @default.
• W2084876139 hasConcept C2777126507 @default.
• W2084876139 hasConcept C2779727114 @default.
• W2084876139 hasConcept C2780057945 @default.
• W2084876139 hasConcept C2780135775 @default.
• W2084876139 hasConcept C2780494398 @default.
• W2084876139 hasConcept C2908997079 @default.
• W2084876139 hasConcept C71924100 @default.
• W2084876139 hasConceptScore W2084876139C118552586 @default.
• W2084876139 hasConceptScore W2084876139C126322002 @default.
• W2084876139 hasConceptScore W2084876139C142724271 @default.
• W2084876139 hasConceptScore W2084876139C168563851 @default.
• W2084876139 hasConceptScore W2084876139C197934379 @default.
• W2084876139 hasConceptScore W2084876139C203092338 @default.
• W2084876139 hasConceptScore W2084876139C204787440 @default.
• W2084876139 hasConceptScore W2084876139C27081682 @default.
• W2084876139 hasConceptScore W2084876139C2776000289 @default.
• W2084876139 hasConceptScore W2084876139C2776412080 @default.
• W2084876139 hasConceptScore W2084876139C2777126507 @default.
• W2084876139 hasConceptScore W2084876139C2779727114 @default.
• W2084876139 hasConceptScore W2084876139C2780057945 @default.
• W2084876139 hasConceptScore W2084876139C2780135775 @default.
• W2084876139 hasConceptScore W2084876139C2780494398 @default.
• W2084876139 hasConceptScore W2084876139C2908997079 @default.
• W2084876139 hasConceptScore W2084876139C71924100 @default.
• W2084876139 hasIssue "4" @default.
• W2084876139 hasLocation W20848761391 @default.
• W2084876139 hasLocation W20848761392 @default.
• W2084876139 hasOpenAccess W2084876139 @default.
• W2084876139 hasPrimaryLocation W20848761391 @default.
• W2084876139 hasRelatedWork W1483000871 @default.
• W2084876139 hasRelatedWork W1590775835 @default.
• W2084876139 hasRelatedWork W1999954638 @default.
• W2084876139 hasRelatedWork W2169110986 @default.
• W2084876139 hasRelatedWork W2318215329 @default.
• W2084876139 hasRelatedWork W2549002080 @default.

• next